CTNND2 and neurodevelopmental disorder: Both the clinical presentation of the 53 individuals reported here with CTNND2-related neurodevelopmental disorders and the in vitro model of three patient-derived and three CRISPR-Cas9 generated neural cell lines show a high degree of variability.